Story
From the other side of the table
I spent twenty years evaluating other people's companies — private equity, venture capital, corporate strategy. You learn quickly what separates a business that compounds from one that merely grows: how much it has to spend to prove it works.
Eventually the analysis stopped being enough. I wanted to be on the other side of the table.
So I built the company I would have backed.
QADR is a bet that the gut microbiome is the next frontier in human health — and that the fastest, cheapest way to prove it is to run the science and the commerce under one roof. GutRecover pursues the clinical thesis. The wellness brands fund it, validate demand, and reach people today.
What makes it unusual is the operating model. There is no team behind me — there is a system. I designed and built the entire stack myself: commerce, CRM, automation, content, finance. Nineteen integrated tools doing the work an operating team would otherwise do. It's not a staffing gap. It's the edge.
The scientific and clinical team is being assembled around GutRecover as it advances toward the clinic.